Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 2/20 | 0.51 |
| ▸ | CFTR | P13569 | 1/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.48 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.48 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.48 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4835362 | 0.80 | CFTR (0.48) | CYP19A1CFTRSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL9959832 | 0.80 | CFTR (0.48) | CYP19A1CFTRSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL7021489 | 0.79 | CYP19A1 (0.55) | CYP19A1CFTRSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL27176403 | 0.77 | CFTR (0.50) | CYP19A1CFTRSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL10446411 | 0.76 | CFTR (0.58) | CYP19A1CFTRSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL10236 | 0.76 | — | — | |
| SCHEMBL30391667 | 0.76 | — | — | |
| SCHEMBL5931850 | 0.76 | CYP19A1 (0.51) | CYP19A1CFTRSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL29860023 | 0.76 | CYP19A1 (0.51) | CYP19A1CFTRSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL6216972 | 0.76 | CYP19A1 (0.51) | CYP19A1CFTRSLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113873989-B | Synergistic anti-inflammatory compositions | 宝洁公司 | 2024-05-28 | — | — | CN | disclosed |
| WO-2024102986-A2 | SARS-COV-2 MPRO INHIBITORS | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2024-05-16 | — | — | WO | disclosed |
| CN-113873986-B | Improving stability of zinc pyrithione in oxidizing environments such as scalp sebum fluids | 宝洁公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-117460810-A | Transparent soap bar | 宝洁公司 | 2024-01-26 | — | — | CN | disclosed |
| CN-112689498-B | Personal cleansing compositions | 宝洁公司 | 2023-10-10 | — | — | CN | disclosed |
| CN-112118824-B | Synergistic antioxidant composition | 宝洁公司 | 2023-05-23 | — | — | CN | disclosed |
| CN-115867356-A | Synergistic anti-inflammatory compositions | 宝洁公司 | 2023-03-28 | — | — | CN | disclosed |
| CN-110831567-B | Hair care composition comprising 2-pyridinol-N-oxide material and an iron chelator | 宝洁公司 | 2023-01-24 | — | — | CN | disclosed |
| CN-109069389-B | Method of treating hair disorders with N-hydroxypyridones | 宝洁公司 | 2022-01-21 | — | — | CN | disclosed |
| CN-113905715-A | Light enhancement processing method | 宝洁公司 | 2022-01-07 | — | — | CN | disclosed |
| CN-103254190-A | Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors | INCYTE CORP | 2013-08-21 | — | — | CN | disclosed |
| CN-103214484-A | Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors | INCYTE CORP A DELAWARE CORP | 2013-07-24 | — | — | CN | disclosed |
| CN-103214483-A | Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors | INCYTE CORP | 2013-07-24 | — | — | CN | disclosed |
| CN-101679287-B | Nicotinic acetylcholine receptor modulators | SIENA BIOTECH SPA | 2013-03-27 | — | — | CN | disclosed |
| CN-101679287-A | nicotinic acetylcholine receptor modulators | SIENA BIOTECH SPA | 2010-03-24 | — | — | CN | disclosed |
| CN-101448826-A | Heteroaryl substituted pyrrolo [2 ] as janus kinase inhibitors | INCYTE CORP (US) | 2009-06-03 | — | — | CN | disclosed |
| US-5286721-A | Antimicrobial agents | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-02-15 | — | — | US | disclosed |
| US-5180827-A | Fungicide Intermediates | RHONE-POULENC AGROCHIMIE (FR) | 1993-01-19 | — | — | US | disclosed |
| WO-1992006978-A1 | 1-AZABICYCLO[3.2.0]HEPT-2-ENE-2-CARBOXYLIC ACID COMPOUNDS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1992-04-30 | — | — | WO | disclosed |
| EP-0372470-A2 | Novel alpha-cyano-beta-oxopropionamides | CIBA-GEIGY AG (CH) | 1990-06-13 | — | — | EP | disclosed |